IRIS
PROVENZANO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.962
NA - Nord America 2.576
SA - Sud America 1.208
EU - Europa 959
AF - Africa 186
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.365
SG - Singapore 2.058
BR - Brasile 861
VN - Vietnam 786
CN - Cina 775
BD - Bangladesh 356
HK - Hong Kong 338
IT - Italia 297
FR - Francia 192
KR - Corea 139
AR - Argentina 127
DE - Germania 98
IN - India 90
IQ - Iraq 90
MX - Messico 83
FI - Finlandia 67
CA - Canada 65
GB - Regno Unito 56
ZA - Sudafrica 55
RU - Federazione Russa 54
EC - Ecuador 49
CO - Colombia 48
ID - Indonesia 42
PK - Pakistan 42
VE - Venezuela 39
NL - Olanda 30
UZ - Uzbekistan 30
UA - Ucraina 28
MA - Marocco 24
PY - Paraguay 24
TR - Turchia 24
PH - Filippine 23
CL - Cile 22
MY - Malesia 22
SA - Arabia Saudita 22
KE - Kenya 21
PL - Polonia 20
TN - Tunisia 17
UY - Uruguay 16
AZ - Azerbaigian 15
EG - Egitto 15
IE - Irlanda 14
DZ - Algeria 13
ET - Etiopia 13
NP - Nepal 13
JO - Giordania 12
PE - Perù 12
CR - Costa Rica 11
ES - Italia 11
SE - Svezia 11
DO - Repubblica Dominicana 10
JP - Giappone 10
MT - Malta 10
PA - Panama 10
AT - Austria 9
KZ - Kazakistan 9
BO - Bolivia 8
HN - Honduras 8
IL - Israele 8
KG - Kirghizistan 8
JM - Giamaica 7
LB - Libano 7
PS - Palestinian Territory 7
SN - Senegal 7
CH - Svizzera 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
OM - Oman 5
BE - Belgio 4
EE - Estonia 4
KH - Cambogia 4
LK - Sri Lanka 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AO - Angola 3
AU - Australia 3
BG - Bulgaria 3
BY - Bielorussia 3
HU - Ungheria 3
MD - Moldavia 3
PT - Portogallo 3
RO - Romania 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AL - Albania 2
BN - Brunei Darussalam 2
BZ - Belize 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HR - Croazia 2
IR - Iran 2
KW - Kuwait 2
LY - Libia 2
ML - Mali 2
NI - Nicaragua 2
NR - Nauru 2
PR - Porto Rico 2
Totale 9.867
Salva come PNG Salva come JPEG
Città #
Singapore 821
San Jose 597
Boardman 344
Hong Kong 336
Ashburn 314
Ho Chi Minh City 293
Hefei 236
Council Bluffs 212
Hanoi 164
Beijing 161
Lauterbourg 141
Seoul 139
Dallas 136
New York 82
São Paulo 80
Los Angeles 61
Helsinki 50
Santa Clara 39
Mexico City 37
Munich 36
Baghdad 34
Rome 34
Da Nang 33
Haiphong 29
Milan 28
Buffalo 26
The Dalles 25
Phoenix 24
Rio de Janeiro 24
Tashkent 24
Guayaquil 23
Tianjin 23
Biên Hòa 22
Chicago 20
Guangzhou 19
Johannesburg 19
Belo Horizonte 18
Dhaka 18
Falkenstein 18
Toronto 18
Amsterdam 17
Atlanta 17
Brooklyn 17
Curitiba 17
Shanghai 17
Warsaw 17
Frankfurt am Main 16
Montreal 16
Naples 16
Brasília 15
Medellín 15
Dublin 14
Hải Dương 14
Nairobi 14
Orem 14
Addis Ababa 13
Baku 13
Bologna 13
Chennai 13
Asunción 12
Boston 12
Denver 12
Montevideo 12
Ribeirão Preto 12
Santiago 12
Thái Bình 12
Campinas 11
Can Tho 11
Cape Town 11
Erbil 11
Guarulhos 11
London 11
Nuremberg 11
Palermo 11
Phủ Lý 11
Birkirkara 10
Ninh Bình 10
Quito 10
Riyadh 10
Amman 9
Bogotá 9
Fortaleza 9
Hyderabad 9
Jakarta 9
Karachi 9
Kuala Lumpur 9
Stockholm 9
Thái Nguyên 9
Bari 8
Bắc Ninh 8
Chandler 8
Ha Long 8
Hillsboro 8
Manchester 8
Mumbai 8
Paris 8
Tunis 8
Turku 8
Bishkek 7
Dakar 7
Totale 5.444
Salva come PNG Salva come JPEG
Nome #
[Semaglutide in Chronic Kidney Disease: Great Enthusiasm. But How Does It Work?] 126
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 117
Artificial intelligence in chronic kidney diseases: methodology and potential applications 112
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review 106
Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease 106
Precision subclassification of type 2 diabetes: a systematic review 100
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine 100
Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis 99
[Epidemiology and prognosis of chronic kidney disease in Italy] 98
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 97
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 96
I disegni di studio utilizzati nella ricerca epidemiologica delle malattie croniche 96
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study 95
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials 95
The Shaggy Aorta Syndrome: an updated review 94
Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD 92
Exploring the Level of Post Traumatic Growth in Kidney Transplant Recipients via Network Analysis 92
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 92
Proteomic Changes Induced by the Immunosuppressant Everolimus in Human Podocytes 91
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis 91
[Finerenone for the treatment of patients with chronic kidney disease] 91
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 91
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review 90
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease 90
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis 90
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 89
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 89
Acute Kidney Injury and Blood Purification Techniques in Severe COVID-19 Patients 89
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 88
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology 88
Precision gestational diabetes treatment: a systematic review and meta-analyses 88
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 88
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 87
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion 85
[Ultrasonography in chronic lithium nephropathy: a case report] 83
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study 83
Precision stratification of prognostic risk factors associated with outcomes in gestational diabetes mellitus: a systematic review 82
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post‐hoc analysis of the ROTATE‐3 study 81
Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis 80
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review 80
Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review 79
Carotid Endarterectomy versus Carotid Artery Stenting With Double-Layer Micromesh Carotid Stent: Contemporary Results of a Single-Center Retrospective Study 79
The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists 78
Omics in chronic kidney disease: Focus on prognosis and prediction 78
Atherosclerotic-nephropathy: an updated narrative review 77
[Role of Ambulatory Blood Pressure Monitoring (ABPM) in chronic kidney patients: a review] 77
Hyperkalemia in CKD: an overview of available therapeutic strategies 77
Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease 77
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 76
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 76
“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy 75
Genotype-stratified treatment for monogenic insulin resistance: a systematic review 74
[Temporal variation of Chronic Kidney Disease's epidemiology] 74
RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study 73
Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy 72
Role of a dual glucose-dependent insulinotropic peptide (GIP)/glucagon-like peptide-1 receptor agonist (twincretin) in glycemic control: From pathophysiology to treatment 72
The use of the Amplatzer Vascular Plug in the prevention of endoleaks during abdominal endovascular aneurysm repair: A systematic literature review on current applications 72
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study 71
Role of Estimated Glomerular Filtration Rate in Clinical Research: The Never-Ending Matter 71
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 71
Ultrasonography of quadriceps femoris muscle and subcutaneous fat tissue and body composition by BIVA in chronic dialysis patients 70
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD) 70
Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation 70
Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease 70
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 68
Improving Kidney Disease Care: One Giant Leap for Nephrology 68
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 68
Generalizability of DAPA-CKD trial to the real-world setting of outpatient CKD clinics in Italy 67
Clinical and Pathological Correlations in Chronic Venous Disease 67
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 67
Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: competing risk analysis in older versus younger patients under nephrology care 67
Coronary Artery Disease in Patients Undergoing Hemodialysis: A Problem that Sounds the Alarm 66
Up-Date on Diabetic Nephropathy 66
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 65
Estimated glomerular filtration rate in observational and interventional studies in chronic kidney disease 65
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 64
Efficacy and Safety of Jotec E-Ventus BX Stent Graft for Iliac Branch Device Procedure: A Retrospective Clinical Study 63
The Use of Demoralization Scale in Italian Kidney Transplant Recipients 62
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease 62
Fabry disease: a rare disorder calling for personalized medicine. 61
Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases 61
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience 60
Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature 60
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis 60
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 60
Workplace Violence towards Healthcare Workers: An Italian Cross-Sectional Survey 59
Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge 57
Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies 56
La gestione dell'iperpotassiemia: nefrologo e cardiologo a confronto [Management of hyperkalemia in Nephrology and Cardiology clinics: reality and perspectives] 56
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 55
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 54
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 54
Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile 54
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria 53
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Renal Function Decline in Patients With Glomerular Diseases 53
Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients 52
Utility of Blood Flow/Resistance Index Ratio (Q x) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 52
Remote patient monitoring in dialysis patients: The "change of pace" for home dialysis | [Monitoraggio da remoto del paziente in dialisi: Il cambio di passo per la dialisi domiciliare?] 52
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 51
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients 51
Totale 7.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 1 0 0 1 2
2022/202321 4 2 0 1 2 2 0 2 6 0 1 1
2023/2024268 1 0 0 1 2 2 1 1 1 1 141 117
2024/20252.483 404 364 91 87 33 111 34 82 369 94 214 600
2025/20267.466 970 345 326 627 1.249 500 989 408 408 605 474 565
Totale 10.242